These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21803099)

  • 21. The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria.
    Karch CP; Doll TAPF; Paulillo SM; Nebie I; Lanar DE; Corradin G; Burkhard P
    J Nanobiotechnology; 2017 Sep; 15(1):62. PubMed ID: 28877692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redefining an epitope of a malaria vaccine candidate, with antibodies against the N-terminal MSA-2 antigen of Plasmodium harboring non-natural peptide bonds.
    Lozano JM; Guerrero YA; Alba MP; Lesmes LP; Escobar JO; Patarroyo ME
    Amino Acids; 2013 Oct; 45(4):913-35. PubMed ID: 23836419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
    Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
    Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
    PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
    Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
    Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
    Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
    Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of a synthetic immunogen: use of the natural immunomodulator polytuftsin in malaria vaccines against RESA antigen of Plasmodium falciparum.
    Pawan K; Ivanov BB; Kabilan L; Rao DN
    Vaccine; 1994 Jul; 12(9):819-24. PubMed ID: 7526572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332.
    Ahlborg N; Andersson R; Perlmann P; Berzins K
    Immunology; 1996 Aug; 88(4):630-5. PubMed ID: 8881768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of an inhibitory monoclonal antibody-defined epitope on a malaria vaccine candidate antigen.
    Ramasamy R; Jones G; Lord R
    Immunol Lett; 1990 Feb; 23(4):305-9. PubMed ID: 1693361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display.
    Crossey E; Frietze K; Narum DL; Peabody DS; Chackerian B
    PLoS One; 2015; 10(7):e0132560. PubMed ID: 26147502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
    Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
    PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple antigen peptide vaccines against Plasmodium falciparum malaria.
    Mahajan B; Berzofsky JA; Boykins RA; Majam V; Zheng H; Chattopadhyay R; de la Vega P; Moch JK; Haynes JD; Belyakov IM; Nakhasi HL; Kumar S
    Infect Immun; 2010 Nov; 78(11):4613-24. PubMed ID: 20823210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif.
    Villard V; Agak GW; Frank G; Jafarshad A; Servis C; Nébié I; Sirima SB; Felger I; Arevalo-Herrera M; Herrera S; Heitz F; Bäcker V; Druilhe P; Kajava AV; Corradin G
    PLoS One; 2007 Jul; 2(7):e645. PubMed ID: 17653272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant.
    Xue X; Ding F; Zhang Q; Pan X; Qu L; Pan W
    Vaccine; 2010 Apr; 28(18):3152-8. PubMed ID: 20197139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum.
    Xu L; Pei X; Berzins K; Chaudhuri A
    Exp Parasitol; 2007 Jul; 116(3):214-24. PubMed ID: 17336297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses of mice with different genetic backgrounds to improved multiepitope, multitarget malaria vaccine candidate antigen FALVAC-1A.
    Kaba SA; Price A; Zhou Z; Sundaram V; Schnake P; Goldman IF; Lal AA; Udhayakumar V; Todd CW
    Clin Vaccine Immunol; 2008 Nov; 15(11):1674-83. PubMed ID: 18784343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural Parasite Exposure Induces Protective Human Anti-Malarial Antibodies.
    Triller G; Scally SW; Costa G; Pissarev M; Kreschel C; Bosch A; Marois E; Sack BK; Murugan R; Salman AM; Janse CJ; Khan SM; Kappe SHI; Adegnika AA; Mordmüller B; Levashina EA; Julien JP; Wardemann H
    Immunity; 2017 Dec; 47(6):1197-1209.e10. PubMed ID: 29195810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis for epitope masking and strain specificity of a conserved epitope in an intrinsically disordered malaria vaccine candidate.
    Morales RAV; MacRaild CA; Seow J; Krishnarjuna B; Drinkwater N; Rouet R; Anders RF; Christ D; McGowan S; Norton RS
    Sci Rep; 2015 May; 5():10103. PubMed ID: 25965408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.